FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308995145> ?p ?o ?g. }

• W4308995145 abstract "Abstract Background Etanercept (ETN) and adalimumab (ADA) are considered equally effective biologicals in the treatment of arthritis in juvenile idiopathic arthritis (JIA) but no studies have compared their impact on patient-reported well-being. The objective of this study was to determine whether ETN and ADA have a differential effect on patient-reported well-being in non-systemic JIA using real-world data. Methods Biological-naive patients without a history of uveitis were selected from the international Pharmachild registry. Patients starting ETN were matched to patients starting ADA based on propensity score and outcomes were collected at time of therapy initiation and 3–12 months afterwards. Primary outcome at follow-up was the improvement in Juvenile Arthritis Multidimensional Assessment Report (JAMAR) visual analogue scale (VAS) well-being score from baseline. Secondary outcomes at follow-up were decrease in active joint count, adverse events and uveitis events. Outcomes were analyzed using linear and logistic mixed effects models. Results Out of 158 eligible patients, 45 ETN starters and 45 ADA starters could be propensity score matched resulting in similar VAS well-being scores at baseline. At follow-up, the median improvement in VAS well-being was 2 (interquartile range (IQR): 0.0 – 4.0) and scores were significantly better ( P = 0.01) for ETN starters (median 0.0, IQR: 0.0 – 1.0) compared to ADA starters (median 1.0, IQR: 0.0 – 3.5). The estimated mean difference in VAS well-being improvement from baseline for ETN versus ADA was 0.89 (95% CI: -0.01 – 1.78; P = 0.06). The estimated mean difference in active joint count decrease was -0.36 (95% CI: -1.02 – 0.30; P = 0.28) and odds ratio for adverse events was 0.48 (95% CI: 0.16 –1.44; P = 0.19). One uveitis event was observed in the ETN group. Conclusions Both ETN and ADA improve well-being in non-systemic JIA. Our data might indicate a trend towards a slightly stronger effect for ETN, but larger studies are needed to confirm this given the lack of statistical significance." @default.
• W4308995145 created "2022-11-20" @default.
• W4308995145 creator A5003568299 @default.
• W4308995145 creator A5004271791 @default.
• W4308995145 creator A5009968617 @default.
• W4308995145 creator A5013390961 @default.
• W4308995145 creator A5019611618 @default.
• W4308995145 creator A5019966799 @default.
• W4308995145 creator A5024162996 @default.
• W4308995145 creator A5038588572 @default.
• W4308995145 creator A5048041647 @default.
• W4308995145 creator A5055162371 @default.
• W4308995145 creator A5055180780 @default.
• W4308995145 creator A5059012807 @default.
• W4308995145 creator A5069508163 @default.
• W4308995145 creator A5073327579 @default.
• W4308995145 creator A5073401297 @default.
• W4308995145 creator A5081608050 @default.
• W4308995145 creator A5089259852 @default.
• W4308995145 creator A5091842805 @default.
• W4308995145 date "2022-11-14" @default.
• W4308995145 modified "2023-10-18" @default.
• W4308995145 title "Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study" @default.
• W4308995145 cites W1922166444 @default.
• W4308995145 cites W1984184285 @default.
• W4308995145 cites W1998366883 @default.
• W4308995145 cites W2033751248 @default.
• W4308995145 cites W2036193982 @default.
• W4308995145 cites W2064520757 @default.
• W4308995145 cites W2075591761 @default.
• W4308995145 cites W2101762349 @default.
• W4308995145 cites W2105190643 @default.
• W4308995145 cites W2111635289 @default.
• W4308995145 cites W2112181558 @default.
• W4308995145 cites W2121748623 @default.
• W4308995145 cites W2134389576 @default.
• W4308995145 cites W2134843796 @default.
• W4308995145 cites W2138153404 @default.
• W4308995145 cites W2170566110 @default.
• W4308995145 cites W2221264044 @default.
• W4308995145 cites W2266853406 @default.
• W4308995145 cites W2276067163 @default.
• W4308995145 cites W2288254939 @default.
• W4308995145 cites W2319774300 @default.
• W4308995145 cites W2340414165 @default.
• W4308995145 cites W2344163114 @default.
• W4308995145 cites W2529174009 @default.
• W4308995145 cites W2550731897 @default.
• W4308995145 cites W2600538123 @default.
• W4308995145 cites W2740011965 @default.
• W4308995145 cites W2796627630 @default.
• W4308995145 cites W2797862713 @default.
• W4308995145 cites W2810478122 @default.
• W4308995145 cites W2905915579 @default.
• W4308995145 cites W2907411305 @default.
• W4308995145 cites W2909097602 @default.
• W4308995145 cites W2914456308 @default.
• W4308995145 cites W2914567765 @default.
• W4308995145 cites W2916862098 @default.
• W4308995145 cites W2917936278 @default.
• W4308995145 cites W2946341504 @default.
• W4308995145 cites W2977275524 @default.
• W4308995145 cites W2995574553 @default.
• W4308995145 cites W3003839108 @default.
• W4308995145 cites W3008555118 @default.
• W4308995145 cites W3014190322 @default.
• W4308995145 cites W3082295914 @default.
• W4308995145 cites W3108240248 @default.
• W4308995145 cites W3109526103 @default.
• W4308995145 cites W3196706348 @default.
• W4308995145 cites W3202782597 @default.
• W4308995145 cites W4214839266 @default.
• W4308995145 cites W4255497843 @default.
• W4308995145 cites W2791148829 @default.
• W4308995145 doi "https://doi.org/10.1186/s12969-022-00763-x" @default.
• W4308995145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36376976" @default.
• W4308995145 hasPublicationYear "2022" @default.
• W4308995145 type Work @default.
• W4308995145 citedByCount "0" @default.
• W4308995145 crossrefType "journal-article" @default.
• W4308995145 hasAuthorship W4308995145A5003568299 @default.
• W4308995145 hasAuthorship W4308995145A5004271791 @default.
• W4308995145 hasAuthorship W4308995145A5009968617 @default.
• W4308995145 hasAuthorship W4308995145A5013390961 @default.
• W4308995145 hasAuthorship W4308995145A5019611618 @default.
• W4308995145 hasAuthorship W4308995145A5019966799 @default.
• W4308995145 hasAuthorship W4308995145A5024162996 @default.
• W4308995145 hasAuthorship W4308995145A5038588572 @default.
• W4308995145 hasAuthorship W4308995145A5048041647 @default.
• W4308995145 hasAuthorship W4308995145A5055162371 @default.
• W4308995145 hasAuthorship W4308995145A5055180780 @default.
• W4308995145 hasAuthorship W4308995145A5059012807 @default.
• W4308995145 hasAuthorship W4308995145A5069508163 @default.
• W4308995145 hasAuthorship W4308995145A5073327579 @default.
• W4308995145 hasAuthorship W4308995145A5073401297 @default.
• W4308995145 hasAuthorship W4308995145A5081608050 @default.
• W4308995145 hasAuthorship W4308995145A5089259852 @default.
• W4308995145 hasAuthorship W4308995145A5091842805 @default.
• W4308995145 hasBestOaLocation W43089951451 @default.
• W4308995145 hasConcept C118487528 @default.

• next